Johnson & Johnson Pleads Guilty to Criminal Charges and is Fined $2.2 Billion for Improperly Marketing Risperdal

Janssen Pharmaceuticals, Inc. (JPI), a Johnson and Johnson company, has pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed the anti-psychotic drug Risperdal for inappropriate uses and paid kickbacks to doctors and nursing homes in prescribing the drug.  JPI will plead guilty to one misdemeanor violation of the Food Drug [...]